Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

Abstract Background The prognosis of children with juvenile dermatomyositis (JDM) has improved remarkably since the 1960's with the use of corticosteroid and immunosuppressive therapy. Yet there remain a minority of children who have refractory disease. Since 2003 the sporadic use of biologics...

Full description

Saved in:
Bibliographic Details
Main Authors: CH Spencer (Author), K Rouster-Stevens (Author), H Gewanter (Author), G Syverson (Author), R Modica (Author), K Schmidt (Author), H Emery (Author), C Wallace (Author), S Grevich (Author), K Nanda (Author), YD Zhao (Author), S Shenoi (Author), S Tarvin (Author), S Hong (Author), C Lindsley (Author), JE Weiss (Author), M Passo (Author), K Ede (Author), A Brown (Author), K Ardalan (Author), W Bernal (Author), ML Stoll (Author), B Lang (Author), R Carrasco (Author), C Agaiar (Author), L Feller (Author), H Bukulmez (Author), R Vehe (Author), H Kim (Author), H Schmeling (Author), D Gerstbacher (Author), M Hoeltzel (Author), B Eberhard (Author), R Sundel (Author), S Kim (Author), AM Huber (Author), A Patwardhan (Author), Pediatric Rheumatologist Collaborators (Author)
Format: Book
Published: BMC, 2017-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available